Ophthalmic CRO unifies clinical environment with Veeva

By Staff reporter

- Last updated on GMT

(Image: Getty/Rawpixel)
(Image: Getty/Rawpixel)
Ora, Inc., an MA-based ophthalmic contract research organization (CRO), has adopted the Veeva Vault Clinical Suite to streamline clinical operations.

The CRO provides preclinical and clinical development services to the ophthalmic drug, drug delivery, and medical devices industries.

To improve visibility throughout its clinical trials, the company has brought together its clinical trial management system (CTMS), electronic trial master file (eTMF), and study start-up applications under the Veeva Vault Clinical Suite​.

“Our partnership with Veeva began well over a year ago when we first implemented Veeva Vault eTMF,"​ explained Edward Leftin, manager of clinical information systems at Ora.

"We then started adding on various clinical and regulatory applications with the latest addition being Veeva Vault CTMS. Ora needed these various system applications, but we also needed a full clinical platform that could scale with our growing organization,"​ he told us.

According to the company, the transition will help its clinical teams manage documents and processes in real-time to improve inspection readiness and accelerate study timelines.

“With Veeva Vault Clinical Suite, we are now able to share trial documents and data in real time with our clients, plus deliver up-to-minute reports and metrics, regardless of where we are in the trial or where the information originated from,"​ added Leftin.

Related news

Related products

show more


Lyophilization Scale-Up and Tech Transfer

Baxter BioPharma Solutions | 12-Mar-2018 | Technical / White Paper

There are few challenges when increasing the scale of production for a solution formulation, but the challenges drastically increase when the formulation...

Leveraging Best Practices in Primary Packaging

Leveraging Best Practices in Primary Packaging

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

When planning a clinical trial, overlooking the importance of primary packaging can be a mistake. From stability concerns to labeling to patient compliance...

VDS groß

Meet the challenges of complex injectables

Vetter Pharma International GmbH | 07-Nov-2017 | Technical / White Paper

In the time it takes from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can...


Process Development for Lyophilized Products

Baxter BioPharma Solutions | 30-Oct-2017 | Application Note

Baxter approaches formulation and process development with the intention of identifying the failure points for the product. Knowing where the product fails...

Related suppliers